Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pfizer
(NY:
PFE
)
25.26
-1.01 (-3.84%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Pfizer
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Be A Smart Investor – Don’t Hold On For Dear Life
March 13, 2024
You have to give credit where it’s due. The bulls have been relentless for almost 18 months, but certainly over the past 5 months.
Via
Talk Markets
Billionaire’s Biotech Bets: 3 Stocks Dominating Bill Gates’ Portfolio
March 13, 2024
One of the primary features of Bill Gates biotech stocks is they are all working towards a cure for HIV and related illnesses.
Via
InvestorPlace
The 3 Most Undervalued Biotech Stocks to Buy in March 2024
March 13, 2024
These 3 undervalued biotech stocks have been left behind so far but things could begin to turn around as we head into March.
Via
InvestorPlace
Will Alphabet 'Storm Back?' Plus: Progressive, D.R. Horton And Pfizer On CNBC's 'Final Trades'
March 13, 2024
On CNBC’s "Halftime Report Final Trades," Joshua Brown of Ritholtz Wealth Management named Pfizer Inc.
Via
Benzinga
7 Elite Blue-Chip Stocks Predicted to Double Your Fortune by 2028
March 13, 2024
Explore three elite blue-chip stocks in interactive media, transaction processing, semiconductors, pharmaceuticals, and telecommunication.
Via
InvestorPlace
Pfizer's Options Frenzy: What You Need to Know
March 11, 2024
Via
Benzinga
Pfizer-Acquired Seagen's Adcetris Combo Therapy Extends Overall Survival Versus Placebo In Patients With Most Common Type Of Lymphoma
March 12, 2024
Pfizer's Phase 3 study reveals Adcetris combo significantly improves overall survival in relapsed/refractory DLBCL. Positive outcomes in progression-free survival and overall response rate.
Via
Benzinga
Pfizer Shifts Strategic Focus, Pivoting From COVID To Cancer Drugs To Recover Market Value
March 11, 2024
Pfizer navigates a strategic shift from Covid to cancer drugs, targeting a 65% biologics share in the oncology pipeline by 2030. With a $43 billion Seagen acquisition doubling experimental programs.
Via
Benzinga
Exposures
COVID-19
Apple And 4 More Stocks On The Rise: Prime Reddit Picks
March 11, 2024
Investors seek undervalued stocks in current market. Redditors share value picks, including Apple, Alphabet, Crocs, Starbucks, and Pfizer.
Via
Benzinga
2 Dirt Cheap Dividend Stocks to Buy and Hold
March 11, 2024
These companies aren't popular on the market right now, but income investors will like them.
Via
The Motley Fool
3 Pharmaceutical Stocks to Buy Hand Over Fist in March
March 11, 2024
There are some great companies at attractive prices in the lucrative pharmaceutical space.
Via
The Motley Fool
1 Bruised Dividend Stock to Buy While It's Cheap, and 1 to Avoid
March 10, 2024
Having a viable recovery plan is key.
Via
The Motley Fool
Obesity Drugs 2024: The Skinny on the Top 3 Weight-Loss Stocks
March 10, 2024
With therapeutics focused on slimming down skyrocketing, it’s time to consider these top weight-loss stocks.
Via
InvestorPlace
Have $2,000? 2 Magnificent Stocks Ready for a Bull Run
March 10, 2024
These stocks are trading down, but investors may be overlooking some important points.
Via
The Motley Fool
3 Dividend Stocks to Buy Hand Over Fist in March
March 10, 2024
Income investors might want to load up on these great dividend stocks.
Via
The Motley Fool
Pharma Stock Roundup: Novo Nordisk's New Obesity Pill Data, Roche, AstraZeneca's Pipeline Updates
March 09, 2024
This week, data from Novo Nordisk’s early-stage study on a new weight loss pill called amycretin showed that it could be more effective than Wegovy. Meanwhile, the FDA approved Johnson & Johnson's lung...
Via
Talk Markets
Exposures
Product Safety
This Gene Therapy Player Duchenne Data Is Impressive, Analyst Upgrades REGENXBIO
March 08, 2024
REGENXBIO's promising gene therapy advancements! RBC Capital Markets upgraded REGENXBIO (RGNX), citing impressive RGX-202 trial results in Duchenne patients.
Via
Benzinga
3 Stock Winners That Are Up 1,000% or More in 2024
March 08, 2024
Dig deep enough, and find a story hot enough, and you can uncover potential stock winners up 1,000%. Here are three.
Via
InvestorPlace
9 Health Care Stocks Whale Activity In Today's Session
March 08, 2024
Via
Benzinga
Retail Traders Ditch Tesla, Apple, Google For Pharma Stocks Like Ozempic-Maker Novo Nordisk And Eli Lilly: JPMorgan
March 08, 2024
Retail traders have been observed to be selling off their shares in the 'Magnificent Seven' tech stocks, with a noticeable shift towards pharmaceutical stocks, according to a recent report by...
Via
Benzinga
3 Cancer-Fighting Biotech Stocks Showing Clinical Trial Promise
March 07, 2024
Discover the pivotal roles of cancer-fighting biotech stocks that are advancing cancer research and subsequently, their financial growth.
Via
InvestorPlace
FDA Approves Pfizer's Leukemia Drug For Kids As Old As One Year
March 07, 2024
"FDA greenlights Pfizer's inotuzumab ozogamicin (Besponsa) for pediatric CD22-positive B-cell ALL. Study: 22/53 achieved CR with 8.2 months median duration.
Via
Benzinga
Exposures
Product Safety
1 Wall Street Analyst Thinks Pfizer Stock Is Going to $45. Is It a Buy Around $26?
March 07, 2024
Betting in favor of this giant's recovery could be smart in the long term.
Via
The Motley Fool
The Short List: 3 Meme Stock Battlegrounds to Keep on Your Radar
March 06, 2024
Explore the ups and downs of 3 meme stocks: Imperial Petroleum, Novavax and MicroCloud, as they navigate market challenges and speculation.
Via
InvestorPlace
Injectable HIV Treatment By ViiV Healthcare Outperforms Oral Therapy, Interim Data Shows
March 06, 2024
Findings from ViiV Healthcare's LATITUDE trial on long-acting HIV treatment. Cabenuva demonstrates superior efficacy in viral load suppression compared to daily oral therapy. Key secondary endpoints...
Via
Benzinga
What's Going On With Pfizer Stock Wednesday?
March 06, 2024
Pfizer shares were trading at 11-year lows this week, but the stock climbed higher Tuesday afternoon after Ritholtz Wealth Management's Josh Brown called it the best opportunity in the market on CNBC's...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
March 06, 2024
Via
Benzinga
Millionaire’s Blueprint: 7 Must-Have Stocks for Your Road to Wealthy Town
March 06, 2024
Discover must-have stocks for wealth for every investor, from healthcare and communication giants to financial and industrial sectors.
Via
InvestorPlace
The Top 3 Stocks for Beginners With Little Money in March 2024
March 05, 2024
Wager on these best stocks for beginners to buy, blending potential with security for those eager to make informed investment choices.
Via
InvestorPlace
Josh Brown Just Bought This Stock Trading At 11-Year Lows, Paying A 6.5% Dividend: 'They Always Find A Way To Rebuild'
March 05, 2024
Ritholtz Wealth Management's Josh Brown believes the best opportunity in the market right now is in a pharmaceutical stock that's trading at the same price it was at more than 10 years ago.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.